Home » Topics » BioWorld Science

BioWorld Science
RSS

Safety and pharmacokinetics of JTP-4819 in healthy volunteers

June 24, 1997

Gemcitabine vs. cisplatin + etoposide for stage III-IV NSCLC

June 24, 1997

Ranitidine for infectious mononucleosis

June 24, 1997

Penclomedine: phase I results in patients with solid tumors

June 24, 1997

Antiasthmatic activity of NPC-17731 in primate model

June 24, 1997

Three-drug therapy shown effective against AIDS

June 24, 1997

SmithKline Beecham introduces ReQuip in Germany

June 24, 1997

Recombinant PAF-AH progresses to phase II for ARDS

June 24, 1997

PBR ligand-melphalan conjugate with promise for brain tumors

June 24, 1997

Schering-Plough isolates potential lead for new schizophrenia drugs from Chinese plant

June 24, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Kymera’s IRF5 degrader shows potential in IBD treatment
BioWorld Science
At the recently concluded Digestive Disease Week, researchers from Kymera Therapeutics Inc. presented preclinical efficacy data on KT-579, a selective oral IRF5...